[Pharmacological studies of a new minor tranquilizer, dipotassium chlorazepate (7-chloro-1,3-dihydro-2-oxo-5-phenyl-1H-1, 4-benzodiazepine 3-carboxylic acid monopotassium salt monopotassium hydroxide). 1. Central action].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001534:Bemegride / Q000037:antagonists & inhibitors; D001552:Benzazepines / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects*; D002540:Cerebral Cortex / Q000187:drug effects; D003975:Diazepam / Q000494:pharmacology; D004285:Dogs; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects; D006591:Hexobarbital / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects; D008032:Limbic System / Q000187:drug effects; D008297:Male; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors; D009538:Nicotine / Q000037:antagonists & inhibitors; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D013331:Strychnine / Q000037:antagonists & inhibitors; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014203:Tremorine / Q000037:antagonists & inhibitors
D000927:Anticonvulsants; D001552:Benzazepines; D014149:Tranquilizing Agents; D001534:Bemegride; D009538:Nicotine; D009020:Morphine; D006591:Hexobarbital; D013331:Strychnine; D001058:Apomorphine; D003975:Diazepam; D014203:Tremorine; D010433:Pentylenetetrazole